Stuart Turner

Head Real World Evidence at Rocket Pharmaceuticals

Stuart Turner is currently the Head of Real World Evidence at Rocket Pharmaceuticals. Prior to this role, Stuart held positions at Regeneron and Novartis Oncology, where Stuart focused on health economics, outcomes research, and real world evidence in various therapeutic areas. Stuart also has experience in pharmacy practice, including roles at Melbourne Health, Royal Melbourne Hospital, and My Chemist. Stuart holds a Master's in Public Health with a focus on Health Economics and International Health from the University of Melbourne.

Links

Previous companies

Novartis logo

Timeline

  • Head Real World Evidence

    January, 2023 - present

View in org chart